ANTIOXIDANTS EFFECTS IN CANCER SURVIVORS: A SHORT PERSPECTIVE.

A Thyagarajan, R P Sahu

Open access · greenAbstract read

In one paragraph

Article in World journal of pharmacy and pharmaceutical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.2field-weighted citation impact, top 41% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A ThyagarajanDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, OH, USA.

R P SahuDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, OH, USA.

Wright State University · US

Funding

Environmental pro-oxidative stressors and immunosuppressionK22ES023850 · NIEHS · WRIGHT STATE UNIVERSITY · PI SAHU, RAVI PRAKASH · 2014 to 2016

$488k

NIEHS NIH HHS K22 ES023850

6 · The paper itself

Abstract

There have been intense debates on the use of antioxidants as neoadjuvant therapy or in combination with anti-cancer agents in the treatment of human malignancies. While the safety and effectiveness of commonly used dietary antioxidants have been thoroughly assessed during chemotherapy and radiation therapy in cancer patients, more detailed analysis of their effects are needed to define its potential use in cancer survivors. Here, we summarize the findings of few comprehensive studies that investigated the potential implications of antioxidants in cancer survivors.

Indexed as

AntioxidantsCancer survivorsNaturally occurring dietary agents

Identifiers

PMID34873570

PMCPMC8645267

OpenAlexW4206862419

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.